TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05248334 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05248334 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04993365 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04251728 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05745467 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05612620 — Predictive Biomarker (PRD): RPL3 mRNA
Genes: RPL3; OK/SW-cl.32
Study NCT05405894 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05265624 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06138756 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT02658396 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT01487044 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05988411 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05077748 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06628830 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05135650 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05531279 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05980208 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05651061 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT06400706 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06348173 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT06348173 — Predictive Biomarker (PRD): IL5RA mRNA
Genes: IL5RA; IL5R
Study NCT06104592 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05251324 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06081270 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06081270 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05451537 — Predictive Biomarker (PRD): FPR1 mRNA
Genes: FPR1
Study NCT05440513 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06264570 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06003270 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05724095 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04543279 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT06523465 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06438354 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05612178 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT05976425 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05673629 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05673629 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06514092 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05653869 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT05268926 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05268926 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05972460 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05614778 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05836896 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05021861 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04782557 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06451328 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT04843787 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00483210 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00483210 — Safety Biomarker (SAF): Peroxisome proliferator-activated receptor alpha
Genes: PPARA
Study NCT04956328 — Predictive Biomarker (PRD): NR1H4 mRNA
Genes: NR1H4; BAR; FXR; HRR1; RIP14
Study NCT05655754 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05697458 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study NCT05716282 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT05398302 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05964361 — Predictive Biomarker (PRD): IL15 mRNA
Genes: IL15
Study NCT05964361 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT05032001 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT05032001 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05601895 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT05056532 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04836780 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04836780 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04836780 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT04836780 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05728255 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05061511 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT05127525 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05061173 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06478212 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT06478212 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT05767684 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT05767684 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05293223 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05974293 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT06347510 — Predictive Biomarker (PRD): IL1RL1 mRNA
Genes: IL1RL1; DER4; ST2; T1
Study NCT05384028 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05067842 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05493592 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT05749055 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT04065672 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06351657 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06206421 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04988581 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study NCT04988581 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04988581 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06456502 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06395337 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT06492746 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06271746 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study NCT05476276 — Predictive Biomarker (PRD): PDPN mRNA
Genes: PDPN; GP36; PSEC0003; PSEC0025
Study NCT05618379 — Predictive Biomarker (PRD): Chromosome 5q
Study NCT06621199 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study NCT06623773 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT00578825 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06568978 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT02764034 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT05231148 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05231148 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT04978298 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04842084 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study NCT04842084 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT06142929 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT05754658 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05754658 — Predictive Biomarker (PRD): TMEM37 mRNA
Genes: TMEM37; PR
Study NCT05267522 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05360680 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT05360680 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT06401421 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT00760032 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT04922151 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05639179 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06376591 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05370677 — Predictive Biomarker (PRD): HBB mRNA
Genes: HBB
Study NCT04617704 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05842096 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04384263 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04561765 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT04879251 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04433988 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06230211 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05020600 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT05873725 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT06362980 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06362980 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06362980 — Predictive Biomarker (PRD): CDK6 mRNA
Genes: CDK6; CDKN6
Study NCT06362980 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05760742 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT05760742 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05760742 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04856553 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05700903 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05704478 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04854681 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT05039892 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT06101589 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04875143 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06074874 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study NCT05419089 — Monitoring Biomarker (MOI): Circulating tumor HPV DNA
Study NCT05419089 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05672979 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06118398 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT05530200 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05530200 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05034965 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04962308 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05858970 — Predictive Biomarker (PRD): CARS1 mRNA
Genes: CARS1; CARS
Study NCT05491993 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05406635 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06297811 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05653076 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT06383728 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06080906 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03643367 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06579352 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06579352 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT06141278 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05276570 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study NCT05405283 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05278338 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05374954 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04966247 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT06090617 — Predictive Biomarker (PRD): NFAT5 mRNA
Genes: NFAT5; KIAA0827; TONEBP
Study NCT04814680 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04779359 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06016881 — Predictive Biomarker (PRD): MIA mRNA
Genes: MIA
Study NCT05125913 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT05125913 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05771610 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05782725 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study NCT06214793 — Predictive Biomarker (PRD): Epithelial cadherin
Genes: CDH1; CDHE; UVO
Study NCT04872114 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05502991 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04495959 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05388864 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05055297 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05093634 — Predictive Biomarker (PRD): POMC mRNA
Genes: POMC
Study NCT05093634 — Predictive Biomarker (PRD): PCSK1 mRNA
Genes: PCSK1; NEC1
Study NCT05093634 — Predictive Biomarker (PRD): LEPROT mRNA
Genes: LEPROT; LEPR; OBR
Study NCT05093634 — Predictive Biomarker (PRD): NCOA1 mRNA
Genes: NCOA1; BHLHE74; SRC1
Study NCT04719273 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06556394 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT06501651 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04852848 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05439499 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05439499 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05217771 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05665140 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05869279 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05081609 — Predictive Biomarker (PRD): TLR7 mRNA
Genes: TLR7; UNQ248/PRO285
Study NCT04632992 — Predictive Biomarker (PRD): TP53INP2 mRNA
Genes: TP53INP2; C20orf110; DOR; PINH
Study NCT06406387 — Predictive Biomarker (PRD): ATRX mRNA
Genes: ATRX; RAD54L; XH2
Study NCT06406387 — Predictive Biomarker (PRD): DAXX mRNA
Genes: DAXX; BING2; DAP6
Study NCT06406387 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT03291470 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT05391490 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06402201 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT04502082 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT04502082 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT05694416 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT05344690 — Predictive Biomarker (PRD): SLMAP mRNA
Genes: SLMAP; KIAA1601; SLAP; UNQ1847/PRO3577
Study NCT06202820 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04481113 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04481113 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04340258 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06240533 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT00027352 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05908019 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05908019 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT04520191 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06026657 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05027048 — Surrogate Endpoint (SUR): Serum calcium
Study NCT05882955 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05300724 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04937556 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06516029 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT06408324 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT05366062 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06519669 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT06094101 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study NCT06021366 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06021366 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06444425 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06343376 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06343376 — Safety Biomarker (SAF): Interleukin 12
Study NCT06343376 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06619834 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03102138 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT06701851 — Predictive Biomarker (PRD): PRRT2 mRNA
Genes: PRRT2
Study NCT06701266 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05828095 — Safety Biomarker (SAF): Interleukin 12
Study NCT06700408 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06304558 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04987125 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06173193 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05196659 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06500052 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06154343 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04878822 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04781959 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04750928 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT04750928 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05734950 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05734950 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT05932667 — Predictive Biomarker (PRD): GATA3 mRNA
Genes: GATA3
Study NCT05897489 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05213195 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study NCT05174078 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05945953 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05885399 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06014229 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT06302218 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT06302218 — Safety Biomarker (SAF): Platelet to lymphocyte
Study NCT04901299 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04901299 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06255457 — Predictive Biomarker (PRD): MVP mRNA
Genes: MVP; LRP
Study NCT05907057 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT05227040 — Predictive Biomarker (PRD): CFI mRNA
Genes: CFI; IF
Study NCT06539234 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT06118060 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04920565 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04920565 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT05753696 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05753696 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06070961 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT06070961 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06438172 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06568640 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05401097 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT05401097 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT06441240 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06441240 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04332588 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05417854 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06540755 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04377932 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT04377932 — Predictive Biomarker (PRD): IL15 mRNA
Genes: IL15
Study NCT05346419 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00002080 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4